Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials.

Literature DB >> 27520380

Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials.

Abstract

While nanotechnology advancements have been applied to pharmaceutical products, the number of approved nanodrugs by global health authorities has not kept pace with research and development investments in the field. This article reviews the history of nanodrug development and provides an industrial context for realistic expectations in the future.

Keywords: liposomes; micelles; nanocrystals; nanomedicine; nanotechnology

Mesh：

Year: 2016 PMID： 27520380 DOI： 10.1208/s12248-016-9970-6

Source DB: PubMed Journal: AAPS J ISSN： 1550-7416 Impact factor: 4.009

15 in total

1. Medicine. The NIH Roadmap.

Authors: Elias Zerhouni
Journal: Science Date: 2003-10-03 Impact factor: 47.728

2. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid.

Authors: J D WATSON; F H CRICK
Journal: Nature Date: 1953-04-25 Impact factor: 49.962

Review 3. History of the medical use of silver.

Authors: J Wesley Alexander
Journal: Surg Infect (Larchmt) Date: 2009-06 Impact factor: 2.150

4. Nanotechnology.

Authors: Robert Langer; Ralph Weissleder
Journal: JAMA Date: 2015-01-13 Impact factor: 56.272

5. Nanomedicine drug development: a scientific symposium entitled "Charting a roadmap to commercialization".

Authors: Gregory Finch; Henry Havel; Mostafa Analoui; Randall W Barton; Anil R Diwan; Meliessa Hennessy; Vijayapal Reddy; Nakissa Sadrieh; Lawrence Tamarkin; Marc Wolfgang; Benjamin Yerxa; Banu Zolnik; Man Liu
Journal: AAPS J Date: 2014-05-13 Impact factor: 4.009

Review 6. Cancer nanomedicines: so many papers and so few drugs!

Authors: Vincent J Venditto; Francis C Szoka
Journal: Adv Drug Deliv Rev Date: 2012-10-01 Impact factor: 15.470

7. Nanomedicine: is the wave cresting?

Authors: Rudy Juliano
Journal: Nat Rev Drug Discov Date: 2013-03 Impact factor: 84.694

8. Facing the truth about nanotechnology in drug delivery.

Authors: Kinam Park
Journal: ACS Nano Date: 2013-09-24 Impact factor: 15.881

Review 9. The big picture on nanomedicine: the state of investigational and approved nanomedicine products.

Authors: Michael L Etheridge; Stephen A Campbell; Arthur G Erdman; Christy L Haynes; Susan M Wolf; Jeffrey McCullough
Journal: Nanomedicine Date: 2012-06-06 Impact factor: 5.307

Review 10. Delivering nanomedicines to patients: a practical guide.

Authors: Mike A W Eaton; Laurent Levy; Olivier M A Fontaine
Journal: Nanomedicine Date: 2015-02-25 Impact factor: 5.307

22 in total

Review 1. Potential Strategies to Reduce Blood Pressure in Treatment-Resistant Hypertension Using Food and Drug Administration-Approved Nanodrug Delivery Platforms.

Authors: Ibra S Fancher; Israel Rubinstein; Irena Levitan
Journal: Hypertension Date: 2019-02 Impact factor: 10.190

Review 2. Application of the combinatorial approaches of medicinal and aromatic plants with nanotechnology and its impacts on healthcare.

Authors: Priyanka Kumari; Suaib Luqman; Abha Meena
Journal: Daru Date: 2019-05-25 Impact factor: 3.117

Review 3. Biomaterials for vaccine-based cancer immunotherapy.

Authors: Rui Zhang; Margaret M Billingsley; Michael J Mitchell
Journal: J Control Release Date: 2018-10-09 Impact factor: 9.776

4. Biodegradable Gold Nanoclusters with Improved Excretion Due to pH-Triggered Hydrophobic-to-Hydrophilic Transition.

Authors: Elizabeth M Higbee-Dempsey; Ahmad Amirshaghaghi; Matthew J Case; Mathilde Bouché; Johoon Kim; David P Cormode; Andrew Tsourkas
Journal: J Am Chem Soc Date: 2020-04-21 Impact factor: 15.419

5. Progress in Nanomedicine: Approved and Investigational Nanodrugs.

Authors: C Lee Ventola
Journal: P T Date: 2017-12

Review 6. Careers in nanomedicine and drug delivery.

Authors: Elizabeth Nance
Journal: Adv Drug Deliv Rev Date: 2019-06-28 Impact factor: 15.470

Review 7. Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges.

Authors: Francisco Rodríguez; Pablo Caruana; Noa De la Fuente; Pía Español; María Gámez; Josep Balart; Elisa Llurba; Ramón Rovira; Raúl Ruiz; Cristina Martín-Lorente; José Luis Corchero; María Virtudes Céspedes
Journal: Biomolecules Date: 2022-06-04

8. Therapeutically reprogrammed nutrient signalling enhances nanoparticulate albumin bound drug uptake and efficacy in KRAS-mutant cancer.

Authors: Ran Li; Thomas S C Ng; Stephanie J Wang; Mark Prytyskach; Christopher B Rodell; Hannes Mikula; Rainer H Kohler; Michelle A Garlin; Douglas A Lauffenburger; Sareh Parangi; Daniela M Dinulescu; Nabeel Bardeesy; Ralph Weissleder; Miles A Miller
Journal: Nat Nanotechnol Date: 2021-05-06 Impact factor: 40.523

Review 9. Nanoparticle delivery system, highly active antiretroviral therapy, and testicular morphology: The role of stereology.

Authors: Edwin Coleridge S Naidu; Samuel Oluwaseun Olojede; Sodiq Kolawole Lawal; Carmen Olivia Rennie; Onyemaechi Okpara Azu
Journal: Pharmacol Res Perspect Date: 2021-05

Review 10. Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy.

Authors: Di Chang; Yuanyuan Ma; Xiaoxuan Xu; Jinbing Xie; Shenghong Ju
Journal: Front Bioeng Biotechnol Date: 2021-06-25